The issuer is solely responsible for the content of this announcement.
AGC Biologics is a leading global biopharmaceutical progression and contract production organization (CDMO) firmly committed to delivering the highest level of service while working side-by-side with our consumers and spouses, every step of the way. class progression and production of mammalian and microbial healing proteins, plasmid DNA (pDNA), messenger RNA (mRNA), viral vectors, and genetically modified cells. Our global network paints span the U. S. , Europe, and Asia, with GMP-compliant facilities in Seattle, Washington. ; Boulder and Longmont, Colorado; Copenhagen, Denmark; Heidelberg, Germany; Milan, Italy; and Chiba, Japan, and lately we employ more than 2,500 painters worldwide. Our commitment to continuous innovation fosters technical creativity to solve our customers’ most complex challenges, adding specialization in fast-track projects and rare diseases. AGC Biologics is the partner of choice. For more information, stop at www. agcbio. com.
© Press 2023
Disclaimer: The content of this press release has been provided through a third-party vendor. This online page is not guilty of such external content and does not. This content is provided on an “as is” and “as available” basis and has not been modified in any way. Neither this website nor our affiliates guarantee the accuracy or endorse the views or reviews expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent, subsidiaries, affiliates, and their respective shareholders, directors, officers, employees, agents, advertisers, content providers, and licensors shall be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive, or exemplary damages, including, but not limited to, lost profits, lost savings, and lost revenue, whether for negligence, tort, contract, or any other theory of liability, even if the parties have been invited to the option or would have merely foreseen such damages.
Get exclusive, financial news and content you can trust, delivered to your inbox.